Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pipeline Vs. Expiring Patents: Eli Lilly's Future
Pipeline Vs. Expiring Patents: Eli Lilly's Future
Pipeline Vs. Expiring Patents: Eli Lilly's Future
Submitted by
admin
on June 20, 2013 - 11:00am
Source:
Seeking Alpha
News Tags:
Eli Lilly
patents
empagliflozin
dulaglutide
ixekizumab
ramucirumab
Headline:
Pipeline Vs. Expiring Patents: Eli Lilly's Future
Do Not Allow Advertisers to Use My Personal information
